CD248 (Endosialin) Antibody, anti-human, PE, REAfinity™, 30 tests in 60 µL
文献支持

CD248 (Endosialin) Antibody, a

nti-human, PE, REAfinity™, 30 tests in 60 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-133-473
  • 2025年12月09日
  • Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      CD248 (Endosialin)

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REA1344

    • 标记物

      PE

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry

    • 浓度

      1:50

    • 抗体英文名

      CD248 (Endosialin) Antibody, anti-human, REAfinity™

    • 抗体名

      CD248 (Endosialin) Antibody, anti-human, REAfinity™

    • 规格

      30 tests in 60 µL

    Identification and enumeration of CD248 (Endosialin)+ cellsClone REA1344 recognizes the human CD248 antigen, also known as Endosalin, Tumor endothelial marker 1 (TEM1) or CD164 sialomucin-like 1 (CD164L1). CD248 is a single-pass type I transmembrane glycoptrotein belonging to the Group XIV, a novel family of C-type lectin transmembrane receptors. CD248 is expressed on tumor endothelial cells, in metastatic lesions of the liver pericytes and on stromal fibroblasts. CD248 is suggested to be involved in tumor angiogenesis,development and growth and in lymphoid tissue organization. | REA1344 displays negligible binding to Fc receptors. |

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Rettig, W. J. (1992) Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc. Natl. Acad. Sci. U.S.A. 89 (22): 10832–10836. | Viski, C. et al. (2016) Endosialin-Expressing Pericytes Promote Metastatic Dissemination. Cancer Res. 76 (18): 5313–5325. | MacFadyen, J. R. et al. (2005) Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett. 579 (12): 2569–2575. | Simonavicius, N. et al. (2008) Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 21 (3): 308–315. | Khan, K. A. et al. (2019) C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation. FEBS J. 286 (17): 3299–3332.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥2904
    武汉佰乐博生物技术有限公司
    2025年07月16日询价
    询价
    普健生物(武汉)科技有限公司
    2025年07月11日询价
    ¥3937
    苏州奕赛生物科技有限公司
    2025年07月14日询价
    文献支持
    CD248 (Endosialin) Antibody, anti-human, PE, REAfinity™, 30 tests in 60 µL
    询价